Efficacy and Saffety of Oral Immunotherapy to Pistachio | Clinical Trial | StuddyBuddy@endsection Efficacy and Saffety of Oral Immunotherapy to Pistachio
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05698030

Efficacy and Saffety of Oral Immunotherapy to Pistachio

Conditions: Allergy, Food Allergy

Sex: All
Ages: 1 Year – 18 Years
Healthy volunteers: 1
Enrollment: 50
Sponsor: Central Hospital, Nancy, France

Location: France

Summary

The objectives of this study are (i) to evaluate the efficacy of oral immunotherapy to pistachio by evaluating the daily oral tolerance of 2g pistachio, by evaluating the long-term tolerance of 15g pistachio (sustained unresponsiveness) and by decreasing pistachio-specific IgE, (ii) evaluating the efficacy of pistachio immunotherapy on cashew tolerance, (iii) and to evaluate the safety of pistachio immunotherapy.

Eligibility Criteria

Inclusion Criteria:Patients under 18 years of age with a proven allergy to pistachio and followed in the pediatric allergology unit of the Nancy University Hospital.Patients who have received oral immunotherapy to pistachio for at least 18 months at 31/12/2022Exclusion Criteria:Patients who have received oral immunotherapy to pistachio for less than 18 months.Patients lost to follow-up for more than 2 years or last consultation dating from 2020 or earlier

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05698030). StuddyBuddy aggregates publicly available trial information.